A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients

Craig S. Sauter, Juliet N. Barker, Lauren Lechner, Junting Zheng, Sean M. Devlin, Esperanza B. Papadopoulos, Miguel‐Angel Perales, Ann A. Jakubowski, Jenna D. Goldberg, Guenther Koehne,

Biology of Blood and Marrow Transplantation · 2013 · 36 citations · 56 references

References

56